| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Daniels Ronald J is a Director at BridgeBio Pharma, Inc.. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 61,031 | $63.72 | $3,888,999.07 | -78.2% | +19.9% | - | |
| Dec 30, 2021 | BBIO Bridgebio Pharma, Inc. | Director | Buy | 22,147 | $13.49 | $298,678.53 | New | -28.7% | -47.6% | |
| Dec 28, 2021 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 11,745 | $12.80 | $150,336.00 | -100% | -22.3% | -49.8% |